Agalsidase Alfa
ATC A16AB03 · 7 markets · 9 records
Agalsidase Alfa
Forms
GB 2 records · 2 strengths
- 3.5 mg/3.5 mLinjectionReplagal 1mg/1ml solution for infusion vials
- 1 mg/1 mLinjectionReplagal 1mg/1ml solution for infusion vials
AU 2 records · 2 strengths
- 1 mg/mLinjectionREPLAGAL agalsidase alfa ghu 3.5mg/3.5mL concentrated injection vial
Records without a stated strength · 1 REPLAGAL
CA 1 records · 1 strengths
- 1 mgliquidREPLAGAL
SG 1 records · 1 strengths
- 1 mg/mLinjectionREPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML
TW 1 records · 1 strengths
- 1 mginjectionREPLAGAL 1MG/ML CONCENTRATION FOR SOLUTION FOR INFUSION利甫蓋素濃縮注射液１毫克/毫升
HK 1 records · 1 strengths
Records without a stated strength · 1 REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 3.5MG/3.5ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 REPLAGAL
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.